Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations
- Angela R. Subauste1,
- Arun K. Das1,
- Xiangquan Li1,
- Brandon Elliot1,
- Charles Evans1,
- Mahmoud El Azzouny2,
- Mary Treutelaar1,
- Elif Oral1,
- Todd Leff3 and
- Charles F. Burant1,4⇓
- 1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
- 2Department of Chemistry, University of Michigan, Ann Arbor, Michigan
- 3Department of Pathology, Wayne State University, Detroit, Michigan
- 4Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan
- Corresponding author: Charles F. Burant, .
Congenital generalized lipodystrophy (CGL), secondary to AGPAT2 mutation is characterized by the absence of adipocytes and development of severe insulin resistance. In the current study, we investigated the adipogenic defect associated with AGPAT2 mutations. Adipogenesis was studied in muscle-derived multipotent cells (MDMCs) isolated from vastus lateralis biopsies obtained from controls and subjects harboring AGPAT2 mutations and in 3T3-L1 preadipocytes after knockdown or overexpression of AGPAT2. We demonstrate an adipogenic defect using MDMCs from control and CGL human subjects with mutated AGPAT2. This defect was rescued in CGL MDMCs with a retrovirus expressing AGPAT2. Both CGL-derived MDMCs and 3T3-L1 cells with knockdown of AGPAT2 demonstrated an increase in cell death after induction of adipogenesis. Lack of AGPAT2 activity reduces Akt activation, and overexpression of constitutively active Akt can partially restore lipogenesis. AGPAT2 modulated the levels of phosphatidic acid, lysophosphatidic acid, phosphatidylinositol species, as well as the peroxisome proliferator–activated receptor γ (PPARγ) inhibitor cyclic phosphatidic acid. The PPARγ agonist pioglitazone partially rescued the adipogenic defect in CGL cells. We conclude that AGPAT2 regulates adipogenesis through the modulation of the lipome, altering normal activation of phosphatidylinositol 3-kinase (PI3K)/Akt and PPARγ pathways in the early stages of adipogenesis.
- Received January 4, 2012.
- Accepted May 24, 2012.
- © 2012 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.